TY  - JOUR
AU  - Cantres Fonseca, Onix
AU  - Aryal, Shambhu
AU  - King, Christopher
AU  - Nathan, Steven
PY  - 2024
DA  - 2024/02/20
TI  - Chronic Lung Allograft Dysfunction, a Review in 2023
JO  - OBM Transplantation
SP  - 207
VL  - 08
IS  - 01
AB  - Chronic allograft dysfunction (CLAD) is one of the leading causes of death after lung transplantation [1]. CLAD is a progressive and irreversible decline in lung function after transplant, manifested as an obstructive, restrictive, or mixed ventilatory impairment without any identifiable etiology as infection or acute rejection. Multiple risk factors have been associated with this condition. Despite its significant effect on the mortality of transplanted patients, there is still a lack of powerfully effective therapies for patients with CLAD. Avoiding and correcting risk factors and close patient monitoring is critical in preventing disease progression. This article will discuss CLAD, the risk factors for developing the umbrella of syndromes under this term, and the current treatment alternatives and management available up to 2023.
SN  - 2577-5820
UR  - https://doi.org/10.21926/obm.transplant.2401207
DO  - 10.21926/obm.transplant.2401207
ID  - Cantres Fonseca2024
ER  -